Stelac Advisory Services LLC Gilead Sciences, Inc. Transaction History

Stelac Advisory Services LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 06, 2020	SELL	$62.63 - $80.22 $125,322 - $160,520	-2,001 Closed	0 $0
Q2 2019 Jul 29, 2019	SELL	$61.87 - $69.38 $23,572 - $26,433	-381 Reduced 15.99%	2,001 $135,000
Q4 2018 Feb 07, 2019	SELL	$60.54 - $79.0 $27,545 - $35,945	-455 Reduced 16.04%	2,382 $149,000
Q3 2018 Nov 08, 2018	BUY	$71.28 - $78.92 $37,778 - $41,827	530 Added 22.97%	2,837 $219,000
Q2 2018 Jul 19, 2018	BUY	$64.88 - $75.68 $28,612 - $33,374	441 Added 23.63%	2,307 $163,000
Q1 2018 May 11, 2018	BUY	$72.84 - $88.8 $135,919 - $165,700	1,866 New	1,866 $141,000
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $761,803 - $894,248	-10,707 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $772,081 - $915,127	10,707	10,707 $867,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Stelac Advisory Services LLC, based on Form 13F filings with the SEC.

Stay updated on Stelac Advisory Services LLC with notifications on news.